TY  - GEN
AU  - Do,Eun-Ju
AU  - Hwang,Sung Wook
AU  - Kim,Sang-Yeob
AU  - Ryu,Yeon-Mi
AU  - Cho,Eun A
AU  - Chung,Eun-Ju
AU  - Park,Sunha
AU  - Lee,Hyo Jeong
AU  - Byeon,Jeong-Sik
AU  - Ye,Byong Duk
AU  - Yang,Dong-Hoon
AU  - Park,Sang Hyoung
AU  - Yang,Suk-Kyun
AU  - Kim,Jin-Ho
AU  - Myung,Seung-Jae
TI  - Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3
SN  - 1440-1746
PY  - 2017///0515
KW  - Animals
KW  - Anti-Inflammatory Agents, Non-Steroidal
KW  - pharmacology
KW  - Anticarcinogenic Agents
KW  - Azoxymethane
KW  - Cell Transformation, Neoplastic
KW  - drug effects
KW  - Colitis
KW  - chemically induced
KW  - Colon
KW  - Colorectal Neoplasms
KW  - etiology
KW  - Dextran Sulfate
KW  - Disease Models, Animal
KW  - Gastrointestinal Agents
KW  - Inflammation Mediators
KW  - metabolism
KW  - Interleukin-6
KW  - Macrophages
KW  - Male
KW  - Mesalamine
KW  - Mice, Inbred C57BL
KW  - Phenylhydrazines
KW  - Phosphorylation
KW  - Probiotics
KW  - Proto-Oncogene Proteins c-bcl-2
KW  - STAT3 Transcription Factor
KW  - Signal Transduction
KW  - Time Factors
KW  - bcl-2-Associated X Protein
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1111/jgh.13280
ER  -